Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000050045 | SCV000957659 | pathogenic | Cohen syndrome | 2018-10-29 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Leu3709Serfs*61) in the VPS13B gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has been observed in individuals affected with Cohen syndrome (PMID: 17990063). ClinVar contains an entry for this variant (Variation ID: 56632). Loss-of-function variants in VPS13B are known to be pathogenic (PMID: 15141358, 16648375, 20461111). For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV000050045 | SCV002797994 | pathogenic | Cohen syndrome | 2022-05-17 | criteria provided, single submitter | clinical testing | |
Juha Muilu Group; Institute for Molecular Medicine Finland |
RCV000050045 | SCV000082454 | probable-pathogenic | Cohen syndrome | no assertion criteria provided | not provided | Converted during submission to Likely pathogenic. |